Cadila Healthcare Ltd - Share Price
CADILAHC
Cadila Healthcare LtdFinancials
Cadila Healthcare LtdNews & Updates
Zydus Cadila receives USFDA final approval for Nortriptyline Hydrochloride Capsules
Feb 25,2021 01:45 PM
The drug will be manufactured at the groups formulation manufacturing facility at the SEZ, Ahmedabad.
Zydus Cadila receives USFDA approval for Nortriptyline Hydrochloride Capsules Feb 25,2021
Cadila Healthcare rises after USFDA nod for anti-depressant drug Feb 25,2021
Sentynl (Zydus Group) acquires Cypriums proprietary rights to CUTX-101 Feb 25,2021
Zydus Cadilas US arm acquires experimental drug from Cyprium for treating Menkes disease Feb 25,2021
Nifty Pharma plummets 200 pts on broad-based selloff; Biocon, Cadila drags most Feb 19,2021
Meeting Type
Meeting Date
Resolution Type | Description Of Resolution | IiAS Recommendation |
---|
Peer Comparison
Name | LTP | PE | Mar Cap | NP Qtr | Div. Yld | Sales Qtr | BV |
---|---|---|---|---|---|---|---|
Sun Pharmaceuticals Industries Ltd | 594.60 | 48.12 | 142,832.41 | 555.55 | 0.67 | 3,366.01 | 106.10 |
Divis Laboratories Ltd | 3,363.10 | 48.11 | 89,416.45 | 461.24 | 0.47 | 1,656.48 | 313.47 |
Dr Reddys Laboratories Ltd | 4,426.55 | 30.95 | 73,580.35 | 443.70 | 0.56 | 3,397.50 | 979.38 |
Cipla Ltd | 787.05 | 23.85 | 63,432.15 | 698.93 | 0.51 | 3,689.88 | 233.61 |
Aurobindo Pharma Ltd | 855.20 | 16.80 | 50,091.89 | 740.51 | 0.35 | 3,701.14 | 246.88 |
Figures of Market Capital(Mar Cap), Quaterly Net Profit(NP Qtr) and Quaterly Sales(Sales Qtr) are in Cr.
Cadila Healthcare LtdSummary & Reports
Cadila Healthcare Ltd is a well known research-oriented, technology-driven pharmaceutical company focused on the research areas of biotechnology, formulations and Active Pharmaceutical Ingredients. They are an Indian based pharmaceutical company having their presence around the world. They are having their manufacturing facilities at Ahmedabad, Ankleshwar and Vadodara in Gujarat, Ponda in Goa, Raigad in Maharashtra and Solan in Himacha... More
Registered Office
Zydus Corporate Park S No 536,Khoraj Sarkhej-Gandhinagar H/W,Ahmedabad, Gujarat,382481
Tell. : +91-079-26868100
Website : http://www.zyduscadila.com
Email : upen.shah@zyduscadila.com
Registrar Office
5th Floor 506 to 508, Navrangpura, Ahmedabad-380009 INDIA
Tell. : +91-79-26465179
Website : www.linkintime.co.in
Email : ahmedabad@linkintime.co.in
Reports by cadila-healthcare-ltd-share-price
Latest Release by cadila-healthcare-ltd-share-price
Result Express
Cadila Healthcare Ltd's Q2FY19 consolidated net profit declines 17.13% yoy to Rs417.50cr
Feb 26, 2021 07:11 PM
The company’s consolidated revenue stood at Rs2,961.20cr, down 8.09% yoy but up 2.33% qoq.
Shareholding Snapshot
Corporate Action
Purpose
Board Meeting
Exp. Date
05 Feb 2021
Annc. Date
27 Jan 2021
CADILA HEALTHCARE LTD.has informed BSE that the meeting of the Board of Directors of the Company is ... More
Purpose
Board Meeting
Exp. Date
02 Nov 2020
Annc. Date
20 Oct 2020
CADILA HEALTHCARE LTD.has informed BSE that the meeting of the Board of Directors of the Company is ... More